PHS
PEN icon

PFM Health Sciences’s Penumbra PEN Stock Holding History

PFM Health Sciences’s Portfolio PEN Stock Details PEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.9M Sell
139,779
-5,392
-4% -$1.83M 4.19% 4
2025
Q4 		$45.1M Sell
145,171
-49,914
-26% -$13.8M 4.5% 4
2025
Q3 		$49.4M Buy
195,085
+28,824
+17% +$7.27M 3.8% 6
2025
Q2 		$42.7M Hold
166,261
– – 3.63% 6
2025
Q1 		$44.5M Hold
166,261
– – 3.23% 9
2024
Q4 		$39.5M Hold
166,261
– – 2.45% 11
2024
Q3 		$32.3M Sell
166,261
-18,850
-10% -$3.56M 1.83% 18
2024
Q2 		$33.3M Buy
185,111
+29,325
+19% +$5.85M 1.65% 22
2024
Q1 		$34.8M Hold
155,786
– – 1.63% 20
2023
Q4 		$39.2M Sell
155,786
-36,620
-19% -$8.09M 2.35% 14
2023
Q3 		$46.5M Sell
192,406
-167,624
-47% -$46.5M 2.19% 16
2023
Q2 		$124M Hold
360,030
– – 4.81% 2
2023
Q1 		$100M Hold
360,030
– – 4.43% 3
2022
Q4 		$80.1M Hold
360,030
– – 2.87% 8
2022
Q3 		$68.3M Buy
360,030
+177,244
+97% +$28.4M 2.47% 9
2022
Q2 		$22.8M Buy
182,786
+16,067
+10% +$2.55M 0.87% 45
2022
Q1 		$37M Sell
166,719
-10,369
-6% -$2.3M 1.38% 32
2021
Q4 		$50.9M Hold
177,088
– – 1.73% 22
2021
Q3 		$47.2M Buy
177,088
+43,329
+32% +$11.6M 1.39% 30
2021
Q2 		$36.7M Buy
133,759
+59,408
+80% +$16.2M 1.15% 34
2021
Q1 		$20.1M Sell
74,351
-125,343
-63% -$32.4M 0.61% 54
2020
Q4 		$34.9M Sell
199,694
-39,703
-17% -$8.7M 1.23% 33
2020
Q3 		$46.5M Buy
239,397
+128,095
+115% +$26.9M 2.15% 10
2020
Q2 		$19.9M Sell
111,302
-6,888
-6% -$1.2M 1.03% 35
2020
Q1 		$19.1M Sell
118,190
-300,602
-72% -$50.6M 1.57% 25
2019
Q4 		$68.8M Sell
418,792
-610,772
-59% -$97.1M 3.28% 6
2019
Q3 		$138M Buy
1,029,564
+257,765
+33% +$39.9M 4.09% 4
2019
Q2 		$123M Buy
771,799
+44,742
+6% +$6.46M 2.35% 8
2019
Q1 		$107M Sell
727,057
-175,841
-19% -$25.1M 2.36% 8
2018
Q4 		$110M Buy
902,898
+177,497
+24% +$23.8M 2.93% 6
2018
Q3 		$109M Buy
725,401
+151,001
+26% +$21.2M 1.59% 15
2018
Q2 		$79.4M Sell
574,400
-72,586
-11% -$10.3M 1.24% 24
2018
Q1 		$74.8M Sell
646,986
-178,526
-22% -$18.4M 1.52% 24
2017
Q4 		$77.7M Buy
825,512
+234,839
+40% +$23.3M 1.84% 18
2017
Q3 		$53.3M Buy
590,673
+163,668
+38% +$14.1M 1.05% 37
2017
Q2 		$37.5M Buy
427,005
+71,398
+20% +$6.06M 1.01% 37
2017
Q1 		$29.7M Buy
355,607
+123,715
+53% +$9.36M 0.74% 54
2016
Q4 		$14.8M Buy
231,892
+24,427
+12% +$1.63M 0.42% 67
2016
Q3 		$15.8M Buy
207,465
+169,279
+443% +$11.7M 0.46% 63
2016
Q2 		$2.27M Sell
38,186
-24,859
-39% -$1.34M 0.07% 75
2016
Q1 		$2.9M Buy
63,045
+16,514
+35% +$772K 0.09% 80
2015
Q4 		$2.5M Sell
46,531
-334,739
-88% -$15.2M 0.08% 64
2015
Q3 		$15.3M Buy
+381,270
New +$15.4M 0.43% 50

Other funds holding PEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFM Health Sciences's PEN Position: Q1 2026 in Review

PFM Health Sciences reduced its Penumbra (PEN) stake by 3.7% in Q1 2026, selling an estimated $1.83M and leaving 139,779 shares worth $45.9M. The position accounts for 4.19% of the portfolio, ranked #4.

PFM Health Sciences first reported a position in PEN in Q3 2015 and has held it in 43 quarters since. The position peaked at $138M in Q3 2019. 482 funds tracked by Wall St. Rank hold PEN as of Q1 2026.

  • PFM Health Sciences held 139,779 shares of Penumbra worth $45.9M as of Q1 2026.
  • PFM Health Sciences sold 5,392 Penumbra shares in Q1 2026, an estimated $1.83M.
  • Penumbra made up 4.19% of PFM Health Sciences's portfolio in Q1 2026, its #4 holding.
  • PFM Health Sciences first reported a position in Penumbra in Q3 2015 and has held it in 43 quarters since.
  • PFM Health Sciences's Penumbra position peaked at $138M in Q3 2019.
  • 482 funds tracked by Wall St. Rank held Penumbra as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.